BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16900551)

  • 1. A sequential procedure for monitoring clinical trials against historical controls.
    Xiong X; Tan M; Boyett J
    Stat Med; 2007 Mar; 26(7):1497-511. PubMed ID: 16900551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous and group sequential conditional probability ratio tests for phase II clinical trials.
    Tan M; Xiong X
    Stat Med; 1996 Oct; 15(19):2037-51. PubMed ID: 8896138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing.
    Tan M; Xiong X; Kutner MH
    Biometrics; 1998 Jun; 54(2):682-95. PubMed ID: 9629648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size re-estimation in group-sequential response-adaptive clinical trials.
    Morgan CC
    Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Termination rules in therapeutic trials. Application of sequential methods in 2 clinical trials in hematology].
    Bénichou J; Lepage E; Chastang C
    Nouv Rev Fr Hematol (1978); 1987; 29(1):87-91. PubMed ID: 3473443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive group sequential test for clinical trials with changing patient population.
    Feng H; Shao J; Chow SC
    J Biopharm Stat; 2007; 17(6):1227-38. PubMed ID: 18027228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential boundaries approach in clinical trials with unequal allocation ratios.
    Jafari P; Ayatollahi SM; Behboodian J
    BMC Med Res Methodol; 2006 Jan; 6():1. PubMed ID: 16412232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal conditional error functions for the control of conditional power.
    Brannath W; Bauer P
    Biometrics; 2004 Sep; 60(3):715-23. PubMed ID: 15339294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standard versus adaptive monitoring procedures: A commentary.
    Fleming TR
    Stat Med; 2006 Oct; 25(19):3305-12; discussion 3313-4, 3326-47. PubMed ID: 16850447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of sequential methods in randomized clinical trials with censored response criteria].
    Benichou J; Chastang C
    Rev Epidemiol Sante Publique; 1986; 34(3):196-208. PubMed ID: 3786877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring pairwise comparisons in multi-armed clinical trials.
    Follmann DA; Proschan MA; Geller NL
    Biometrics; 1994 Jun; 50(2):325-36. PubMed ID: 8068834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-designing trial combined with classical group sequential monitoring.
    Yin G; Shen Y
    J Biopharm Stat; 2005; 15(4):667-75. PubMed ID: 16022171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential testing for efficacy in clinical trials with non-transient effects.
    Troendle JF; Liu A; Wu C; Yu KF
    Stat Med; 2005 Nov; 24(21):3239-50. PubMed ID: 16206248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethics and errors of clinical trials and the role and place of different types of trial.
    Mathé G; Reizenstein P
    Drugs Exp Clin Res; 1986; 12(1-3):1-9. PubMed ID: 3732046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of futility in clinical trials.
    Snapinn S; Chen MG; Jiang Q; Koutsoukos T
    Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interim analysis in clinical trials: a methodological guide].
    Muñoz Navarro SR; Bangdiwala SI
    Rev Med Chil; 2000 Aug; 128(8):935-41. PubMed ID: 11129556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative designs of phase II trials considering response and toxicity.
    Jin H
    Contemp Clin Trials; 2007 Jul; 28(4):525-31. PubMed ID: 17428744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design considerations in crossover trials with a single interim analysis and serial patient entry.
    Cook RJ; Willan AR
    Biometrics; 1996 Jun; 52(2):732-9. PubMed ID: 8672709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.